Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

SHA:688016 Revenue

Shanghai MicroPort Endovascular MedTech had revenue of 300.35M CNY in the quarter ending September 30, 2025, with 64.68% growth. This brings the company's revenue in the last twelve months to 1.25B, down -1.32% year-over-year. In the year 2024, Shanghai MicroPort Endovascular MedTech had annual revenue of 1.21B with 1.61% growth.

• Revenue (ttm): 1.25B
• Revenue Growth: -1.32%
• P/S Ratio: 9.48
• Revenue / Employee: 1.52M
• Employees: 826
• Market Cap: 11.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.21B	19.12M	1.61%
Dec 31, 2023	1.19B	290.70M	32.43%
Dec 31, 2022	896.50M	211.87M	30.95%
Dec 31, 2021	684.63M	214.38M	45.59%
Dec 31, 2020	470.25M	136.52M	40.91%